-
UBS Reiterates Neutral Rating on Premier, Inc. (PINC)
-
Premier (PINC) call put ratio 1 call to 3.2 puts into Premier to be acquired by Patient Square Capital for $28.25 per share in cash
-
Premier, Inc. (PINC) PT Raised to $28.25 at Leerink Partners
-
Premier to be acquired by Patient Square Capital for $2.6 billion
-
Premier Inc. signs five-year group purchasing deal with infusion pharmacy
-
Premier shares surge on report Patient Square Capital is exploring acquisition
-
Premier, Inc. (PINC) PT Raised to $28 at Piper Sandler as 'SCS Drives F4Q Beat'
-
Premier, Inc. (PINC) PT Raised to $26 at UBS
-
Premier, Inc. (PINC) PT Raised to $25 at Canaccord Genuity
-
Premier, Inc. (PINC) PT Raised to $21 at BofA Securities
-
Premier, Inc. (PINC) PT Raised to $26 at Leerink Partners
-
Premier (PINC) Tops Q4 EPS by 12c; offers guidance
-
Premier, Inc. (PINC) PT Raised to $24 at Piper Sandler
-
Premier (PINC) Tops Q3 EPS by 16c
-
Premier (PINC) Declares $0.21 Quarterly Dividend; 4.2% Yield
-
Premier (PINC) Enters Into $200 Million Accelerated Share Repurchase Program
-
Benchmark Reiterates Hold Rating on Premier, Inc. (PINC)
-
Premier, Inc. (PINC) PT Lowered to $19 at Canaccord Genuity
-
Premier (PINC) Misses Q2 EPS by 4c ; Offers Guidance
-
Premier (PINC) Mentioned as Short at Jehoshaphat Research
-
Premier (PINC) Appoints David Zito as President, Performance Services
-
Premier, Inc. (PINC) PT Raised to $19 at BofA Securities
-
Premier (PINC) Tops Q1 EPS by 9c; offers guidance
-
Premier, Inc. (PINC) PT Lowered to $19 at Canaccord Genuity
-
Premier (PINC) Divests Ownership Position in S2S Global
-
Benchmark Downgrades Premier, Inc. (PINC) to Hold
-
Premier, Inc. (PINC) PT Lowered to $21 at Piper Sandler
-
Premier, Inc. (PINC) PT Lowered to $20 at Canaccord Genuity
-
Premier, Inc. (PINC) PT Lowered to $19 at Baird
-
Premier (PINC) Appoints Glenn Coleman as Chief Administrative and Financial Officer
-
Premier, Inc. (PINC) PT Raised to $195 at Argus

